Somatic alterations (or mutations) and transcriptional dysregulation of FOXO isoforms are infrequent in multiple human cancers, unlike other tumour suppressors such as TP53 (commonly known as p53) and Adenomatous polyposis coli (APC; Supplementary Figures 1a–d). This evidence concerns the gene TP53 and neoplasm.